Cerevel Therapeutics Holdings Inc logo

Cerevel Therapeutics Holdings Inc Share Price Today (NASDAQ: CERE)

Cerevel Therapeutics Holdings Inc share price is $0 & ₹0.00 as on 30 Jul 2024 IST

-44.96

(-100%)

Market is closed - opens 7 PM, 14 Jul 2025

Bell Icon

The stock has been delisted from the stock exchange on 31 Jul 2024

View live Cerevel Therapeutics Holdings Inc share price in Dollar and Rupees. Guide to invest in Cerevel Therapeutics Holdings Inc stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Cerevel Therapeutics Holdings Inc, along with analyst recommendations, forecasts, and comprehensive financials.

Cerevel Therapeutics Holdings Inc (CERE) Key Statistics

in dollars & INR

Previous Close
$44.96
Open
$44.99
Market Capitalization
$8.2B
Today's Volume
$15.0M
Revenue TTM
$0.0
EBITDA
$-484.5M
Earnings Per Share (EPS)
$-2.73
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-92.45%

How to invest in Cerevel Therapeutics Holdings Inc Stock (CERE) from India?

It is very easy for Indian residents to invest directly in Cerevel Therapeutics Holdings Inc from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Cerevel Therapeutics Holdings Inc stock in both Indian Rupees (INR) and US Dollars (USD). Search for Cerevel Therapeutics Holdings Inc or CERE on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Cerevel Therapeutics Holdings Inc or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Cerevel Therapeutics Holdings Inc shares which would translate to null fractional shares of Cerevel Therapeutics Holdings Inc as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Cerevel Therapeutics Holdings Inc, in just a few clicks!

Global Institutional Holdings in Cerevel Therapeutics Holdings Inc

  • Bain Capital Investors LLC

    36.05%

  • Perceptive Advisors LLC

    5.92%

  • venBio Select Advisor LLC

    4.15%

  • Vanguard Group Inc

    4.10%

  • BlackRock Inc

    2.99%

  • State Street Corporation

    1.94%

Analyst Recommendation on Cerevel Therapeutics Holdings Inc

Rating
Trend

Hold

    0%Buy

    78%Hold

    21%Sell

Based on 14 Wall street analysts offering stock ratings for Cerevel Therapeutics Holdings Inc(by analysts ranked 0 to 5 stars)

About Cerevel Therapeutics Holdings Inc

Cerevel Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, develops various therapies for neuroscience diseases in the United States. It is developing Emraclidine, a positive allosteric modulator (PAM) that is in phase 1b clinical trials for the treatment of schizophrenia; and Darigabat, a PAM, which is in Phase 2 proof-of-concept trial in patients with drug-resistant focal onset seizures or focal epilepsy, as well as in phase 1 trial to treat panic symptoms model. The company's products also comprise Tavapadon, a selective dopamine D1/D5 partial agonist that is in phase 3 clinical trial for the treatment of early- and late-stage Parkinson's disease; CVL-871, a selective dopamine D1/D5 partial agonist, which is in Phase 2a clinical trial to treat dementia-related apathy; and CVL-354, a selective kappa-opioid receptor antagonist to treat major depressive disorder and substance use disorder. It is also involved in the development of an M4 agonist program for the treatment of psychosis and related indications; and PDE4 inhibitor for the treatment of psychiatric, neuroinflammatory, and other disorders. Cerevel Therapeutics Holdings, Inc. was founded in 2018 and is headquartered in Cambridge, Massachusetts.
Organization
Cerevel Therapeutics Holdings Inc
Employees
355
CEO
Dr. N. Anthony Coles Jr., M.P.H.
Industry
Finance

Important FAQs about investing in CERE Stock from India :

Can Indians buy Cerevel Therapeutics Holdings Inc shares?

Yes, Indians can invest in the Cerevel Therapeutics Holdings Inc (CERE) from India.

With INDmoney, you can buy Cerevel Therapeutics Holdings Inc at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Cerevel Therapeutics Holdings Inc at zero transaction cost.

How can I buy Cerevel Therapeutics Holdings Inc shares from India?

It is very easy to buy Cerevel Therapeutics Holdings Inc from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Cerevel Therapeutics Holdings Inc (CERE) be purchased?

Yes, you can buy fractional shares of Cerevel Therapeutics Holdings Inc with INDmoney app.

What are the documents required to start investing in Cerevel Therapeutics Holdings Inc stocks?

To start investing in Cerevel Therapeutics Holdings Inc, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What is today's market capitalisation of Cerevel Therapeutics Holdings Inc?

Today's market capitalisation of Cerevel Therapeutics Holdings Inc CERE is 8.2B

Who is the Chief Executive Officer (CEO) of Cerevel Therapeutics Holdings Inc ?

Dr. N. Anthony Coles Jr., M.P.H. is the current Chief Executive Officer (CEO) of Cerevel Therapeutics Holdings Inc.